Sacroiliac Joint DysfunctionNCT07600359
Comparative Effects of Autogenic Inhibition and Reciprocal Inhibition Technique on Pain, Functional Disability and Gait in Sacroiliac Joint Dysfuction.
A study testing Autogenic Inhibition and Reciprocal Inhibition in people with Sacroiliac Joint Dysfunction and Muscle Energy Techniques, run by Foundation University Islamabad at 1 site in Pakistan.
Trial summary
Sacro-iliac joint act as the shock absorber of the body. It is responsible for transferring vertical load of the whole body to lower limb hence contributing to stability of pelvic girdle. Read more about this study
- Who is it for?
- Ages 25 to 45 years
- Conditions the study is for
- Sacroiliac Joint Dysfunction, Muscle Energy Techniques
- What is being tested?
- Autogenic Inhibition and Reciprocal Inhibition
- Type of treatment
- Surgery or procedure
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 40 participants
- Where
- 1 sitePakistan
- Study dates
- 15 May 2026to 15 Jul 2026
- Phase
- Interventional
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 25 to 45 years
- All sexes
- No healthy volunteers
- Adult
Who may be able to join
- Patients having low back pain greater than 4 weeks
- Patients with positive gaenslen's test, thigh thurst test, standing flexion test, sacral compression and distraction test.
- Patients not having any other condition that can affect gait
- 25-45 years
- Both males and females
Who cannot join
- Patients having nonspecific low back
- Patients with lumbosacral fusion
- Patients with any neurological condition
- Patients with history of trauma of spine
- Patients with any other lumbar spine condition (lumbar radiculopathy, spinal stenosis, spondylolisthesis, inflammatory arthritis)
- Patients with any hip joint pathology
- Patients using any assistive device
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
Pakistan1 site, 1 recruiting
- Recruiting
Foundation University College of Physical Therapy
Islamabad, Punjab Province, 44000
Fajar Sajjad, DPT, 0331-5817637, fajarsajjad1999@gmail.com
Marwa Asim, MS-OMPT, 03335339457, marwa@fui.edu.pk
About this study
Sacro-iliac joint act as the shock absorber of the body. It is responsible for transferring vertical load of the whole body to lower limb hence contributing to stability of pelvic girdle. However, SI joint dysfunction is one of the most common causes of low back pain among the patients suffering from non-radicular low back pain. There can be a mechanical source which is due to muscle insufficiency or instability or a non-mechanical source which is osteoarthritis, infection or any trauma. It is thought to affect females more commonly with prevalence of about 46.71% in females and with the prevalence of about 15 to 30% in general. This poses great threat to bio mechanics of the body which can significantly lead to disability that can affect mobility, daily activities and quality of life of the individual. According to a study the pain caused by SIJD caused activity limitation and participation restriction of about 25% of the individuals. Hence making it difficult for them to continue their jobs. increased pain leads to worsening of the ability to perform ADLs which ultimately effects the quality of life. Altered biomechanics also leads to alteration in spatio temporal gait parameters.This study aims to compare the effects of autogenic inhibition technique and reciprocal inhibition technique in addition with conventional therapy in reliving low back pain, improving functional disability and alteration in spatio-temporal gait parameters in patients with sacroiliac joint dysfunction. Patients with SIJD will be recruited and will be randomly divided into two groups 20 in each group. Group 1 will receive autogenic inhibition technique of iliopsas, hamstrings, erector spinae and piriformis muscles along with standard core stabilization exercises and group 2 will receive reciprocal inhibition technique on iliopsas, hamstrings, erector spinae and piriformis muscles along with standard core stabilization exercises. The treatment will be continued for 3 weeks with 4 sessions of 25 minutes per week.
Read the detailed description
Participants will be divided into two groups and a total of 12 sessions will be given for 3 weeks with a frequency of 4 sessions per week and a duration of 25 minutes. Group 1 will be given autogenic inhibition technique of iliopsoas, Piriformis, hamstrings and erector spinae along with core stability exercises and conentional therapy. Group 2 will be given reciprocal inhibition techniques of iliopsoas, Piriformis, hamstrings and erector spinae along with conventional treatment and core stability exercises.
Group 1 Group 2 WEEK 1 4 SESSEIONS/ WEEK
- TENS + hot pack ⇢10 mins
- drawing in maneuver in quadruped position ⇢7 reps ⇢3 sec hold
- Bridiging ⇢5 reps ⇢no hold
- PIR of illiopsoas ⇢5 reps ⇢10 sec hold
- PIR of PIRiformis ⇢5 reps ⇢10 sec hold
- PIR of hamstrings ⇢5 reps ⇢10 sec hold
- PIR of erector spinae ⇢5 reps ⇢10 sec hold • TENS + hot pack ⇢10 mins
- drawing in maneuver in quadruped position ⇢7 reps ⇢3 sec hold
- Bridiging ⇢5 reps ⇢no hold
- RI-MET of illiopsoas ⇢5 reps ⇢10 sec hold
- RI-MET of PIRiformis ⇢5 reps ⇢10 sec hold
- RI-MET of hamstrings ⇢5 reps ⇢10 sec hold
- RI-MET of erector spinae ⇢5 reps ⇢10 sec hold Group 1 Group 2 WEEK 2 4 SESSEIONS/ WEEK
- TENS + hot pack ⇢10 mins
- drawing in manuver in quadruped position ⇢7 reps ⇢6 sec hold
- Bridiging ⇢5reps ⇢3 sec hold
- Clam shell exercises ⇢6 reps
- PIR of illiopsoas ⇢7 reps ⇢10 sec hold
- PIR of PIRiformis ⇢7 reps ⇢10 sec hold
- PIR of hamstrings ⇢ 7 reps ⇢10 sec hold
- PIR of erector spinae ⇢7 reps ⇢10 sec hold • TENS + hot pack ⇢10 mins
- drawing in manuver in quadruped position ⇢7 reps ⇢6 sec hold
- Bridiging ⇢5reps ⇢3 sec hold
- Clam shell exercises ⇢6 reps
- RI-MET of illiopsoas ⇢7 reps ⇢10 sec hold
- RI-MET of PIRiformis ⇢7 reps ⇢10 sec hold
- RI-MET of hamstrings ⇢ 7 reps ⇢10 sec hold
- RI-MET of erector spinae ⇢7 reps ⇢10 sec hold
Group 1 Group 2 WEEK 3 4 SESSEIONS/ WEEK
- TENS + hot pack ⇢10 mins
- drawing in manuver in quadruped position ⇢8 reps ⇢8 sec hold
- Supine Bridiging ⇢10 reps ⇢ 6 sec hold
- Clam shell exercises ⇢10 reps ⇢6 sec hold
- PIR of illiopsoas ⇢10 reps ⇢10 sec hold
- PIR of PIRiformis ⇢10 reps ⇢10 sec hold
- PIR of hamstrings ⇢10 reps ⇢ 10 sec hold
- PIR of erector spinae ⇢ 10 reps ⇢10 sec hold
- TENS + hot pack ⇢10 mins
- drawing in manuver in quadruped position ⇢8 reps ⇢8 sec hold
- Supine Bridiging ⇢10 reps ⇢ 6 sec hold
- Clam shell exercises ⇢10 reps ⇢6 sec hold
- RI-MET of illiopsoas ⇢10 reps ⇢10 sec hold
- RI-MET of PIRiformis ⇢10 reps ⇢10 sec hold
- RI-MET of hamstrings ⇢10 reps ⇢ 10 sec hold
- RI-MET of erector spinae ⇢ 10 reps ⇢10 sec hold
- Being tested
- Autogenic Inhibition, Reciprocal Inhibition
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Autogenic InhibitionProcedure or surgery
During week 1, group 1 will receive TENS + hot pack ⇢10 mins Drawing in maneuver in quadruped position Bridiging PIR of illiopsoas,Piriformis, hamstrings,erector spinae During week 2, group 1 will receive TENS + hot pack ⇢10 mins Drawing in manuver in quadruped position Bridiging Clam shell exercises PIR of illiopsoas, PIRiformis, hamstrings, erector spinae During week 3, group 1 will receive TENS + hot pack ⇢10 mins Drawing in manuver in quadruped position Supine Bridiging, Clam shell exercises, PIR of illiopsoas PIR of Piriformis, hamstrings and erector spinae
Reciprocal InhibitionProcedure or surgery
During week 1, group 2 will receive TENS + hot pack ⇢10 mins Drawing in maneuver in quadruped position ⇢7 reps ⇢3 sec hold Bridiging ⇢5 reps ⇢no hold RI-MET of illiopsoas, PIRiformis, hamstrings, erector spinae ⇢5 reps ⇢10 sec hold During week 2, group 2 will receive TENS + hot pack ⇢10 mins Drawing in manuver in quadruped position ⇢7 reps ⇢6 sec hold Bridiging ⇢5reps ⇢3 sec hold Clam shell exercises ⇢6 reps RI-MET of illiopsoas, PIRiformis, hamstrings, erector spinae ⇢7 reps ⇢10 sec hold During week 3, group 2 will receive TENS + hot pack ⇢10 mins drawing in manuver in quadruped position ⇢8 reps ⇢8 sec hold Supine Bridiging, Clam shell exercises ⇢10 reps ⇢6 sec hold RI-MET of illiopsoas, Piriformis, erector spinae ⇢10 reps ⇢10 sec hold
| Study group | Role | What they receive |
|---|---|---|
| Autogenic Inhibition Technique | Experimental | During week 1, group 1 will receive TENS + hot pack ⇢10 mins Drawing in maneuver in quadruped position ⇢7 reps ⇢3 sec hold Bridiging ⇢5 reps ⇢no hold PIR of illiopsoas ⇢5 reps ⇢10 sec hold PIR of PIRiformis ⇢5 reps ⇢10 sec hold PIR of hamstrings ⇢5 reps ⇢10 sec hold PIR of erector spinae ⇢5 reps ⇢10 sec hold
During week 2, group 1 will receive TENS + hot pack ⇢10 mins Drawing in manuver in quadruped position ⇢7 reps ⇢6 sec hold Bridiging ⇢5reps ⇢3 sec hold Clam shell exercises ⇢6 reps PIR of illiopsoas ⇢7 reps ⇢10 sec hold PIR of PIRiformis ⇢7 reps ⇢10 sec hold PIR of hamstrings ⇢ 7 reps ⇢10 sec hold PIR of erector spinae ⇢7 reps ⇢10 sec hold
During week 3, group 1 will receive TENS + hot pack ⇢10 mins Drawing in manuver in quadruped position ⇢8 reps ⇢8 sec hold Supine Bridiging ⇢10 reps ⇢ 6 sec hold Clam shell exercises ⇢10 reps ⇢6 sec hold PIR of illiopsoas ⇢10 reps ⇢10 sec hold PIR of PIRiformis ⇢10 reps ⇢10 sec hold PIR of hamstrings ⇢10 reps ⇢ 10 sec Receives: Procedure: Autogenic Inhibition |
| Reciprocal Inhibition Technique | Experimental | During week 1, group 2 will receive TENS + hot pack ⇢10 mins Drawing in maneuver in quadruped position ⇢7 reps ⇢3 sec hold Bridiging ⇢5 reps ⇢no hold RI-MET of illiopsoas ⇢5 reps ⇢10 sec hold RI-MET of PIRiformis ⇢5 reps ⇢10 sec hold RI-MET of hamstrings ⇢5 reps ⇢10 sec hold RI-MET of erector spinae ⇢5 reps ⇢10 sec hold
During week 2, group 2 will receive TENS + hot pack ⇢10 mins Drawing in manuver in quadruped position ⇢7 reps ⇢6 sec hold Bridiging ⇢5reps ⇢3 sec hold Clam shell exercises ⇢6 reps RI-MET of illiopsoas ⇢7 reps ⇢10 sec hold RI-MET of PIRiformis ⇢7 reps ⇢10 sec hold RI-MET of hamstrings ⇢ 7 reps ⇢10 sec hold RI-MET of erector spinae ⇢7 reps ⇢10 sec hold
During week 3, group 2 will receive TENS + hot pack ⇢10 mins drawing in manuver in quadruped position ⇢8 reps ⇢8 sec hold Supine Bridiging ⇢10 reps ⇢ 6 sec hold Clam shell exercises ⇢10 reps ⇢6 sec hold RI-MET of illiopsoas ⇢10 reps ⇢10 sec hold RI-MET of PIRiformis ⇢10 reps ⇢10 sec hold RI-MET o Receives: Procedure: Reciprocal Inhibition |
What is being measured
The primary outcome is the main question the study is designed to answer.
Functional disability
It will be measured by using Denver SI joint disability questionnaire which 10 questions questionnaire consisting of scoring range from 0-5 in each item answered. 0 means no disability and 5 means maximum disability. And total score is calculated in the form of percentage. Higher the percentage greater is the disability.
Measured: before treatment after after 3 weeks
Pain intensity
Pain will be measured by NPRS. A line of 10 centimeters containing numbers from 0 to 10 marked. The starting point of the scale indicates 0 or no pain whereas the ending point marks the pain as 10 which means the pain is as worse as it could be.
Measured: before treatment and after 3 weeks
Gait Speed
Gait speed will be measured by calculating the distance covered in meters divided by the time taken in seconds during walking assessment.
Formula: Gait Speed (m/s) = Distance (m) × Time (s)
Measured: Assessed at baseline (before intervention) and after 3 weeks of intervention.
Cadance
Cadence will be measured as the number of steps taken per minute during walking assessment.
Formula: Cadence (steps/min) = Steps Counted × 60 / Time (s)
Measured: Assessed at baseline (before intervention) and after 3 weeks of intervention.
Cycle time
Cycle time will be calculated as the time required to complete one gait cycle during walking assessment.
Formula: Cycle Time (s) = Time (s) × 2 / Steps Counted
Measured: Assessed at baseline (before intervention) and after 3 weeks of intervention.
Stride Length
Stride length will be determined by multiplying gait speed with cycle time during walking assessment.
Formula: Stride Length (m) = Speed (m/s) × Cycle Time (s)
Measured: Assessed at baseline (before intervention) and after 3 weeks of intervention.
Step Length
Step length will be calculated as half of the stride length obtained during gait assessment.
Formula: Step Length (m) = Stride Length / 2
Measured: Assessed at baseline (before intervention) and after 3 weeks of intervention.
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted20 May 2026
- Study start15 May 2026 (estimated)
- Primary completion1 Jul 2026 (estimated)
- Study completion15 Jul 2026 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Sacroiliac Joint DysfunctionStudies of the same condition, open and under way.
- More trials run by Foundation University IslamabadThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Model description
- Randomized Control trial
- Masking
- None (open label)
- Enrolment
- 40 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Foundation University Islamabad
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
- Investigators
- Fajar Sajjad, DPT, Principal investigator, Foundation University Islamabad
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07600359
- Sponsor's protocol ID
- FUI/FUCP/CTR/10.26/FajarSajad
- Status last verified
- May 2026
- First submitted
- 14 May 2026
- Last updated
- 20 May 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
Study at a glance
From the registry record, last updated by the sponsor on 20 May 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Comparative Effects of Autogenic Inhibition and Reciprocal Inhibition Technique on Pain, Functional Disability and Gait in Sacroiliac Joint Dysfuction.
- ClinicalTrials.gov ID
- NCT07600359
- Acronym / sponsor ID
- FUI/FUCP/CTR/10.26/FajarSajad
- Study type
- Interventional
- Recruitment status
- Recruiting
- Enrolment
- 40 participants (estimated)
- Lead sponsor
- Foundation University IslamabadUniversity, hospital or other
- Study start
- 15 May 2026 (estimated)
- Primary completion
- 1 Jul 2026 (estimated)
- Study completion
- 15 Jul 2026 (estimated)
- First posted
- 20 May 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Sacro-iliac joint act as the shock absorber of the body. It is responsible for transferring vertical load of the whole body to lower limb hence contributing to stability of pelvic girdle. However, SI joint dysfunction is one of the most common causes of low back pain among the patients suffering from non-radicular low back pain. There can be a mechanical source which is due to muscle insufficiency or instability or a non-mechanical source which is osteoarthritis, infection or any trauma. It is thought to affect females more commonly with prevalence of about 46.71% in females and with the prevalence of about 15 to 30% in general. This poses great threat to bio mechanics of the body which can significantly lead to disability that can affect mobility, daily activities and quality of life of the individual. According to a study the pain caused by SIJD caused activity limitation and participation restriction of about 25% of the individuals. Hence making it difficult for them to continue their jobs. increased pain leads to worsening of the ability to perform ADLs which ultimately effects the quality of life. Altered biomechanics also leads to alteration in spatio temporal gait parameters.This study aims to compare the effects of autogenic inhibition technique and reciprocal inhibition technique in addition with conventional therapy in reliving low back pain, improving functional disability and alteration in spatio-temporal gait parameters in patients with sacroiliac joint dysfunction. Patients with SIJD will be recruited and will be randomly divided into two groups 20 in each group. Group 1 will receive autogenic inhibition technique of iliopsas, hamstrings, erector spinae and piriformis muscles along with standard core stabilization exercises and group 2 will receive reciprocal inhibition technique on iliopsas, hamstrings, erector spinae and piriformis muscles along with standard core stabilization exercises. The treatment will be continued for 3 weeks with 4 sessions of 25 minutes per week.
Detailed description
Participants will be divided into two groups and a total of 12 sessions will be given for 3 weeks with a frequency of 4 sessions per week and a duration of 25 minutes. Group 1 will be given autogenic inhibition technique of iliopsoas, Piriformis, hamstrings and erector spinae along with core stability exercises and conentional therapy. Group 2 will be given reciprocal inhibition techniques of iliopsoas, Piriformis, hamstrings and erector spinae along with conventional treatment and core stability exercises.
Group 1 Group 2 WEEK 1 4 SESSEIONS/ WEEK
- TENS + hot pack ⇢10 mins
- drawing in maneuver in quadruped position ⇢7 reps ⇢3 sec hold
- Bridiging ⇢5 reps ⇢no hold
- PIR of illiopsoas ⇢5 reps ⇢10 sec hold
- PIR of PIRiformis ⇢5 reps ⇢10 sec hold
- PIR of hamstrings ⇢5 reps ⇢10 sec hold
- PIR of erector spinae ⇢5 reps ⇢10 sec hold • TENS + hot pack ⇢10 mins
- drawing in maneuver in quadruped position ⇢7 reps ⇢3 sec hold
- Bridiging ⇢5 reps ⇢no hold
- RI-MET of illiopsoas ⇢5 reps ⇢10 sec hold
- RI-MET of PIRiformis ⇢5 reps ⇢10 sec hold
- RI-MET of hamstrings ⇢5 reps ⇢10 sec hold
- RI-MET of erector spinae ⇢5 reps ⇢10 sec hold Group 1 Group 2 WEEK 2 4 SESSEIONS/ WEEK
- TENS + hot pack ⇢10 mins
- drawing in manuver in quadruped position ⇢7 reps ⇢6 sec hold
- Bridiging ⇢5reps ⇢3 sec hold
- Clam shell exercises ⇢6 reps
- PIR of illiopsoas ⇢7 reps ⇢10 sec hold
- PIR of PIRiformis ⇢7 reps ⇢10 sec hold
- PIR of hamstrings ⇢ 7 reps ⇢10 sec hold
- PIR of erector spinae ⇢7 reps ⇢10 sec hold • TENS + hot pack ⇢10 mins
- drawing in manuver in quadruped position ⇢7 reps ⇢6 sec hold
- Bridiging ⇢5reps ⇢3 sec hold
- Clam shell exercises ⇢6 reps
- RI-MET of illiopsoas ⇢7 reps ⇢10 sec hold
- RI-MET of PIRiformis ⇢7 reps ⇢10 sec hold
- RI-MET of hamstrings ⇢ 7 reps ⇢10 sec hold
- RI-MET of erector spinae ⇢7 reps ⇢10 sec hold
Group 1 Group 2 WEEK 3 4 SESSEIONS/ WEEK
- TENS + hot pack ⇢10 mins
- drawing in manuver in quadruped position ⇢8 reps ⇢8 sec hold
- Supine Bridiging ⇢10 reps ⇢ 6 sec hold
- Clam shell exercises ⇢10 reps ⇢6 sec hold
- PIR of illiopsoas ⇢10 reps ⇢10 sec hold
- PIR of PIRiformis ⇢10 reps ⇢10 sec hold
- PIR of hamstrings ⇢10 reps ⇢ 10 sec hold
- PIR of erector spinae ⇢ 10 reps ⇢10 sec hold
- TENS + hot pack ⇢10 mins
- drawing in manuver in quadruped position ⇢8 reps ⇢8 sec hold
- Supine Bridiging ⇢10 reps ⇢ 6 sec hold
- Clam shell exercises ⇢10 reps ⇢6 sec hold
- RI-MET of illiopsoas ⇢10 reps ⇢10 sec hold
- RI-MET of PIRiformis ⇢10 reps ⇢10 sec hold
- RI-MET of hamstrings ⇢10 reps ⇢ 10 sec hold
- RI-MET of erector spinae ⇢ 10 reps ⇢10 sec hold
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Number of arms
- 2
- Model description
- Randomized Control trial
| Arm | Type | Receives |
|---|---|---|
| Autogenic Inhibition Technique | Experimental | Procedure: Autogenic InhibitionDuring week 1, group 1 will receive TENS + hot pack ⇢10 mins Drawing in maneuver in quadruped position ⇢7 reps ⇢3 sec hold Bridiging ⇢5 reps ⇢no hold PIR of illiopsoas ⇢5 reps ⇢10 sec hold PIR of PIRiformis ⇢5 reps ⇢10 sec hold PIR of hamstrings ⇢5 reps ⇢10 sec hold PIR of erector spinae ⇢5 reps ⇢10 sec hold During week 2, group 1 will receive TENS + hot pack ⇢10 mins Drawing in manuver in quadruped position ⇢7 reps ⇢6 sec hold Bridiging ⇢5reps ⇢3 sec hold Clam shell exercises ⇢6 reps PIR of illiopsoas ⇢7 reps ⇢10 sec hold PIR of PIRiformis ⇢7 reps ⇢10 sec hold PIR of hamstrings ⇢ 7 reps ⇢10 sec hold PIR of erector spinae ⇢7 reps ⇢10 sec hold During week 3, group 1 will receive TENS + hot pack ⇢10 mins Drawing in manuver in quadruped position ⇢8 reps ⇢8 sec hold Supine Bridiging ⇢10 reps ⇢ 6 sec hold Clam shell exercises ⇢10 reps ⇢6 sec hold PIR of illiopsoas ⇢10 reps ⇢10 sec hold PIR of PIRiformis ⇢10 reps ⇢10 sec hold PIR of hamstrings ⇢10 reps ⇢ 10 sec |
| Reciprocal Inhibition Technique | Experimental | Procedure: Reciprocal InhibitionDuring week 1, group 2 will receive TENS + hot pack ⇢10 mins Drawing in maneuver in quadruped position ⇢7 reps ⇢3 sec hold Bridiging ⇢5 reps ⇢no hold RI-MET of illiopsoas ⇢5 reps ⇢10 sec hold RI-MET of PIRiformis ⇢5 reps ⇢10 sec hold RI-MET of hamstrings ⇢5 reps ⇢10 sec hold RI-MET of erector spinae ⇢5 reps ⇢10 sec hold During week 2, group 2 will receive TENS + hot pack ⇢10 mins Drawing in manuver in quadruped position ⇢7 reps ⇢6 sec hold Bridiging ⇢5reps ⇢3 sec hold Clam shell exercises ⇢6 reps RI-MET of illiopsoas ⇢7 reps ⇢10 sec hold RI-MET of PIRiformis ⇢7 reps ⇢10 sec hold RI-MET of hamstrings ⇢ 7 reps ⇢10 sec hold RI-MET of erector spinae ⇢7 reps ⇢10 sec hold During week 3, group 2 will receive TENS + hot pack ⇢10 mins drawing in manuver in quadruped position ⇢8 reps ⇢8 sec hold Supine Bridiging ⇢10 reps ⇢ 6 sec hold Clam shell exercises ⇢10 reps ⇢6 sec hold RI-MET of illiopsoas ⇢10 reps ⇢10 sec hold RI-MET of PIRiformis ⇢10 reps ⇢10 sec hold RI-MET o |
Who may qualify
- Ages
- 25 to 45 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult
Key inclusion criteria (5 listed)
- Patients having low back pain greater than 4 weeks
- Patients with positive gaenslen's test, thigh thurst test, standing flexion test, sacral compression and distraction test.
- Patients not having any other condition that can affect gait
- 25-45 years
- Both males and females
Key exclusion criteria (7 listed)
- Patients having nonspecific low back
- Patients with lumbosacral fusion
- Patients with any neurological condition
- Patients with history of trauma of spine
- Patients with any other lumbar spine condition (lumbar radiculopathy, spinal stenosis, spondylolisthesis, inflammatory arthritis)
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Autogenic InhibitionDuring week 1, group 1 will receive TENS + hot pack ⇢10 mins Drawing in maneuver in quadruped position Bridiging PIR of illiopsoas,Piriformis, hamstrings,erector spinae During week 2, group 1 will receive TENS + hot pack ⇢10 mins Drawing in manuver in quadruped position Bridiging Clam shell exercises PIR of illiopsoas, PIRiformis, hamstrings, erector spinae During week 3, group 1 will receive TENS + hot pack ⇢10 mins Drawing in manuver in quadruped position Supine Bridiging, Clam shell exercises, PIR of illiopsoas PIR of Piriformis, hamstrings and erector spinae | Procedure or surgery | Autogenic Inhibition Technique |
| Reciprocal InhibitionDuring week 1, group 2 will receive TENS + hot pack ⇢10 mins Drawing in maneuver in quadruped position ⇢7 reps ⇢3 sec hold Bridiging ⇢5 reps ⇢no hold RI-MET of illiopsoas, PIRiformis, hamstrings, erector spinae ⇢5 reps ⇢10 sec hold During week 2, group 2 will receive TENS + hot pack ⇢10 mins Drawing in manuver in quadruped position ⇢7 reps ⇢6 sec hold Bridiging ⇢5reps ⇢3 sec hold Clam shell exercises ⇢6 reps RI-MET of illiopsoas, PIRiformis, hamstrings, erector spinae ⇢7 reps ⇢10 sec hold During week 3, group 2 will receive TENS + hot pack ⇢10 mins drawing in manuver in quadruped position ⇢8 reps ⇢8 sec hold Supine Bridiging, Clam shell exercises ⇢10 reps ⇢6 sec hold RI-MET of illiopsoas, Piriformis, erector spinae ⇢10 reps ⇢10 sec hold | Procedure or surgery | Reciprocal Inhibition Technique |
Primary outcome
Functional disability
Time frame: before treatment after after 3 weeks
It will be measured by using Denver SI joint disability questionnaire which 10 questions questionnaire consisting of scoring range from 0-5 in each item answered. 0 means no disability and 5 means maximum disability. And total score is calculated in the form of percentage. Higher the percentage greater is the disability.
Pain intensity
Time frame: before treatment and after 3 weeks
Pain will be measured by NPRS. A line of 10 centimeters containing numbers from 0 to 10 marked. The starting point of the scale indicates 0 or no pain whereas the ending point marks the pain as 10 which means the pain is as worse as it could be.
Gait Speed
Time frame: Assessed at baseline (before intervention) and after 3 weeks of intervention.
Gait speed will be measured by calculating the distance covered in meters divided by the time taken in seconds during walking assessment. Formula: Gait Speed (m/s) = Distance (m) × Time (s)
Cadance
Time frame: Assessed at baseline (before intervention) and after 3 weeks of intervention.
Cadence will be measured as the number of steps taken per minute during walking assessment. Formula: Cadence (steps/min) = Steps Counted × 60 / Time (s)
Cycle time
Time frame: Assessed at baseline (before intervention) and after 3 weeks of intervention.
Cycle time will be calculated as the time required to complete one gait cycle during walking assessment. Formula: Cycle Time (s) = Time (s) × 2 / Steps Counted
Stride Length
Time frame: Assessed at baseline (before intervention) and after 3 weeks of intervention.
Stride length will be determined by multiplying gait speed with cycle time during walking assessment. Formula: Stride Length (m) = Speed (m/s) × Cycle Time (s)
Step Length
Time frame: Assessed at baseline (before intervention) and after 3 weeks of intervention.
Step length will be calculated as half of the stride length obtained during gait assessment. Formula: Step Length (m) = Stride Length / 2
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 20 May 2026.
Related trials for Sacroiliac Joint Dysfunction
Not yet recruiting
Effect of Retro Walking in Patients With Sacroiliac Joint Dysfunction
Sacroiliac Joint Dysfunction
RecruitingObservational study
Real World Evidence of SI-BONE's iFuse TORQ TNT Advancing Treatment of Pelvic Ring Fractures
Fracture; Pelvic, Insufficiency Fractures
Not yet recruiting
Comparison of High-Intensity and Conventional Physical Therapy in Musculoskeletal Disorders
Low Back Pain, Radicular Syndrome
Not yet recruitingObservational study
Correlation Between Trunk Muscles Endurance and Dynamic Balance in Sacroiliac Joint Dysfunction
Trunk Extensor Muscle Endurance
Active, not recruitingObservational study
Post-Market Clinical Study on a Modular SI Joint Fusion System
Sacroiliitis, Sacroiliac Joint Dysfunction
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
Fajar Sajjad, DPT principal investigator
Foundation University Islamabad
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Autogenic Inhibition and Reciprocal Inhibition in people with Sacroiliac Joint Dysfunction and Muscle Energy Techniques, run by Foundation University Islamabad at 1 site in Pakistan.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 5 inclusion and 7 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: looking for participants now, as of the sponsor's last update on 20 May 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Pakistan. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Fajar Sajjad, DPT (0331-5817637, fajarsajjad1999@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Functional disability (time frame: before treatment after after 3 weeks). The study lists 7 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 20 May 2026.